- Accueil
- 98 054 508 ds
- Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
4.8 (446) · € 17.99 · En Stock
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
Subclinical Atherosclerosis: Part 1: What Is it? Can it Be Defined at the Histological Level?
Janet POWELL, Imperial College London, London, Imperial, BHF Centre of Research Excellence
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents
Frontiers Innovative Approaches to Assess Intermediate Cardiovascular Risk Subjects: A Review From Clinical to Metabolomics Strategies
Subclinical Atherosclerosis: Part 1: What Is it? Can it Be Defined at the Histological Level?
Assessment of Subclinical Atherosclerosis in Asymptomatic People In Vivo: Measurements Suitable for Biomarker and Mendelian Randomization Studies
Genetics: Implications for Prevention and Management of Coronary Artery Disease
Chapter 1: Introduction, 2007
PDF) Transcriptomic-based clustering of human atherosclerotic plaques identifies subgroups with different underlying biology and clinical presentation
Frontiers Biomarker Discovery in Atherosclerotic Diseases Using Quantitative Nuclear Magnetic Resonance Metabolomics
